Unichem Laboratories gets ANDA approval for Ranolazine Extended-Release Tablets

17 Mar 2023 Evaluate

Unichem Laboratories has received ANDA approval for its Ranolazine Extended-Release Tablets, 500 mg and 1000 mg from the United States Food and Drug Administration (USFDA) to market a generic version of Ranexa (ranolazine extended-release tablets) 500 mg and 1000 mg, of Gilead Sciences Inc.

Ranolazine Extended-Release Tablets, 500 mg, and 1000 mg are indicated for the treatment of chronic angina. The product will be commercialized from Unichem’s Goa Plant.

Unichem Laboratories is an international, integrated, specialty pharmaceutical company.

Unichem Lab Share Price

315.60 -14.90 (-4.51%)
04-Mar-2026 09:07 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1720.35
Dr. Reddys Lab 1256.05
Cipla 1351.95
Zydus Lifesciences 899.15
Lupin 2260.05
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×